Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Exercise ventilatory inefficiency in mild to end-stage COPD.

Neder JA, Arbex FF, Alencar MC, O'Donnell CD, Cory J, Webb KA, O'Donnell DE.

Eur Respir J. 2015 Feb;45(2):377-87. doi: 10.1183/09031936.00135514. Epub 2014 Oct 30.

2.

Ventilation Distribution Heterogeneity at Rest as a Marker of Exercise Impairment in Mild-to-Advanced COPD.

Neder JA, O'Donnell CD, Cory J, Langer D, Ciavaglia CE, Ling Y, Webb KA, O'Donnell DE.

COPD. 2015 Jun;12(3):249-56. doi: 10.3109/15412555.2014.948997. Epub 2014 Sep 17.

PMID:
25230258
3.

The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccines.

O'Donnell CD, Vogel L, Matsuoka Y, Jin H, Subbarao K.

J Virol. 2014 Nov;88(21):12374-84. doi: 10.1128/JVI.01107-14. Epub 2014 Aug 13.

4.

Humans and ferrets with prior H1N1 influenza virus infections do not exhibit evidence of original antigenic sin after infection or vaccination with the 2009 pandemic H1N1 influenza virus.

O'Donnell CD, Wright A, Vogel L, Boonnak K, Treanor JJ, Subbarao K.

Clin Vaccine Immunol. 2014 May;21(5):737-46. doi: 10.1128/CVI.00790-13. Epub 2014 Mar 19.

5.

Respiratory Consequences of Mild-to-Moderate Obesity: Impact on Exercise Performance in Health and in Chronic Obstructive Pulmonary Disease.

O'Donnell DE, O'Donnell CD, Webb KA, Guenette JA.

Pulm Med. 2012;2012:818925. doi: 10.1155/2012/818925. Epub 2012 Oct 14.

6.

Effect of priming with H1N1 influenza viruses of variable antigenic distances on challenge with 2009 pandemic H1N1 virus.

O'Donnell CD, Wright A, Vogel LN, Wei CJ, Nabel GJ, Subbarao K.

J Virol. 2012 Aug;86(16):8625-33. doi: 10.1128/JVI.00147-12. Epub 2012 Jun 6.

7.

Antibody pressure by a human monoclonal antibody targeting the 2009 pandemic H1N1 virus hemagglutinin drives the emergence of a virus with increased virulence in mice.

O'Donnell CD, Vogel L, Wright A, Das SR, Wrammert J, Li GM, McCausland M, Zheng NY, Yewdell JW, Ahmed R, Wilson PC, Subbarao K.

MBio. 2012 May 29;3(3). pii: e00120-12. doi: 10.1128/mBio.00120-12. Print 2012.

8.

The contribution of animal models to the understanding of the host range and virulence of influenza A viruses.

O'Donnell CD, Subbarao K.

Microbes Infect. 2011 May;13(5):502-15. doi: 10.1016/j.micinf.2011.01.014. Epub 2011 Jan 27. Review.

9.

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection.

Wrammert J, Koutsonanos D, Li GM, Edupuganti S, Sui J, Morrissey M, McCausland M, Skountzou I, Hornig M, Lipkin WI, Mehta A, Razavi B, Del Rio C, Zheng NY, Lee JH, Huang M, Ali Z, Kaur K, Andrews S, Amara RR, Wang Y, Das SR, O'Donnell CD, Yewdell JW, Subbarao K, Marasco WA, Mulligan MJ, Compans R, Ahmed R, Wilson PC.

J Exp Med. 2011 Jan 17;208(1):181-93. doi: 10.1084/jem.20101352. Epub 2011 Jan 10. Erratum in: J Exp Med. 2011 Feb 14;208(2):411.

10.

Expanding the role of 3-O sulfated heparan sulfate in herpes simplex virus type-1 entry.

O'Donnell CD, Kovacs M, Akhtar J, Valyi-Nagy T, Shukla D.

Virology. 2010 Feb 20;397(2):389-98. doi: 10.1016/j.virol.2009.11.011. Epub 2009 Dec 11.

11.

The Importance of Heparan Sulfate in Herpesvirus Infection.

O'Donnell CD, Shukla D.

Virol Sin. 2008 Dec 1;23(6):383-393.

12.

A novel function of heparan sulfate in the regulation of cell-cell fusion.

O'Donnell CD, Shukla D.

J Biol Chem. 2009 Oct 23;284(43):29654-65. doi: 10.1074/jbc.M109.037960. Epub 2009 Sep 2.

13.

A role for heparan sulfate 3-O-sulfotransferase isoform 2 in herpes simplex virus type 1 entry and spread.

O'Donnell CD, Tiwari V, Oh MJ, Shukla D.

Virology. 2006 Mar 15;346(2):452-9. Epub 2005 Dec 5.

14.

A role for 3-O-sulfotransferase isoform-4 in assisting HSV-1 entry and spread.

Tiwari V, O'Donnell CD, Oh MJ, Valyi-Nagy T, Shukla D.

Biochem Biophys Res Commun. 2005 Dec 16;338(2):930-7. Epub 2005 Oct 21.

PMID:
16259945

Supplemental Content

Loading ...
Support Center